Next generation citizen centric e-services

The emergence of new technology calls for fundamental rethinking and transformational shifts in the way we look at government functions and its service provisioning to the public. Governments are increasingly being solicited to take on the roles of a facilitator and enabler – to collaborate with the public, private and community sectors in creating new digital channels and solutions to be closer to citizens and businesses. This paper deliberates on the role of the Mauritian Government for creating a society of the future for citizens. To build a one stop shop model for public services, Government is required to view itself through different lenses: citizen-centricity, internal-external balance and sustainable outcomes. Servicing citizens digitally has been a successful model across developed countries. This model has to be embraced and adapted locally under Public and Private Partnerships

Role of three dimensional (3D) printing in endourology: An update from EAU young academic urologists (YAU) urolithiasis and endourology working group

The management of nephrolithiasis has been complemented well by modern technological advancements like virtual reality, three-dimensional (3D) printing etc. In this review, we discuss the applications of 3D printing in treating stone disease using percutaneous nephrolithotomy (PCNL) and retrograde intrarenal surgery (RIRS). PCNL surgeries, when preceded by a training phase using a 3D printed model, aid surgeons to choose the proper course of action, which results in better procedural outcomes. The 3D printed models have also been extensively used to train junior residents and novice surgeons to improve their proficiency in the procedure. Such novel measures include different approaches employed to 3D print a model, from 3D printing the entire pelvicalyceal system with the surrounding tissues to 3D printing simple surgical guides.publishedVersio

Cinnamon as a Potential Feed Additive: Beneficial Effects on Poultry Health and Production Performances – An Update

According to the Food and Agricultural Organization, global poultry output increased from approximately 115 million tons in 2016 to around 136 million tons in 2023. Poultry production has increased significantly with the dramatic uptick in meat and egg demand. Feed accounts for between 65 and 70 percent of total production costs, making it the largest chicken industry expense. This is why it's important to maximize the transformation of poultry feed into feed with a high biological value while taking as many steps as possible to protect feed quality and reduce feed costs. The use of feed additives in poultry feed has recently gained popularity and has been essential to increase feed efficiency and growth rate, which typically leads to reduced costs. The meat's texture, consistency, and nutritional content are all improved, and its shelf life is lengthened as a bonus. Feed additives are a fantastic tool for boosting a poultry farm's bottom line. For example, cinnamon (Cinnamomum verum) is often used as a traditional feed supplement. Rather than antibiotics, the poultry industry could benefit from using cinnamon as a natural antibiotic replacement, which would benefit animal welfare, consumer health, and the bottom line. The performance index, feed intake, FCE performance, and weight growth of poultry can all be improved by including cinnamon in the feed at varied concentrations. The digestive health and intestinal microbial population of hens are enhanced by a diet containing bioactive components of cinnamon. Cinnamon essential oils' popularity stems from their many valuable features, such as their ability to increase gastric enzyme synthesis and other biofunctional benefits. This review focuses on the possible advantages of cinnamon as a natural feed supplement for chickens, particularly about their intestinal microbiota, blood chemistry, nutrient absorption, gene expression, and immunology

Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries

Background: Balancing opioid stewardship and the need for adequate analgesia following discharge after surgery is challenging. This study aimed to compare the outcomes for patients discharged with opioid versus opioid-free analgesia after common surgical procedures.Methods: This international, multicentre, prospective cohort study collected data from patients undergoing common acute and elective general surgical, urological, gynaecological, and orthopaedic procedures. The primary outcomes were patient-reported time in severe pain measured on a numerical analogue scale from 0 to 100% and patient-reported satisfaction with pain relief during the first week following discharge. Data were collected by in-hospital chart review and patient telephone interview 1 week after discharge.Results: The study recruited 4273 patients from 144 centres in 25 countries; 1311 patients (30.7%) were prescribed opioid analgesia at discharge. Patients reported being in severe pain for 10 (i.q.r. 1-30)% of the first week after discharge and rated satisfaction with analgesia as 90 (i.q.r. 80-100) of 100. After adjustment for confounders, opioid analgesia on discharge was independently associated with increased pain severity (risk ratio 1.52, 95% c.i. 1.31 to 1.76; P < 0.001) and re-presentation to healthcare providers owing to side-effects of medication (OR 2.38, 95% c.i. 1.36 to 4.17; P = 0.004), but not with satisfaction with analgesia (beta coefficient 0.92, 95% c.i. -1.52 to 3.36; P = 0.468) compared with opioid-free analgesia. Although opioid prescribing varied greatly between high-income and low- and middle-income countries, patient-reported outcomes did not.Conclusion: Opioid analgesia prescription on surgical discharge is associated with a higher risk of re-presentation owing to side-effects of medication and increased patient-reported pain, but not with changes in patient-reported satisfaction. Opioid-free discharge analgesia should be adopted routinely

Triple Winter Epidemic (Influenza, RSV, SARS COV2): How to Deal with These

Not Availabl